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ABSTRACT 
It is the need of the day to identify the new anticancer herbal drug, which not only in possession 
of good anticancer effects but also cost effective. Here we are presenting such an anticancer 
Ayurvedic herb which is used since the centuries for the treatment of different diseases of 
diverse origin. Eclipta alba Hassk., also called as Bhringraj is very important medicinal herb in 
many medicinal formulations. Though it is commonly used for hair growth, many evidences 
found its hepatoprotective activity. 
 Here we are presenting all aspects about Bhringraj in terms of qualitative and quantitative 
values and we have also tried to prove the anticancer activity of it for hepatic cancer. We have 
used the aqueous extract of Eclipta alba Hassk. for phytochemical analysis, TLC, HPLC analysis to 
test active chemical components in it. Extract showed presence of many active chemical 
components which were responsible for its anticancer activity. In vitro study we used the 
aqueous extract of Eclipta alba Hassk. for the evaluation of its effects on HepG2 (Human liver 
cancer cell line). The SRB assay results were used to evaluate the anti-cancer activity of the 
extract. The effects of whole plant extract on cancer cell line were studied. Percentage of cell 
growth and cell viability were calculated from tabulated result values of srb assay. The 
experiment revealed that the average percentage of growth inhibition was 68.74%. Cell viability 
SRB assay also showed significant growth inhibition, at the same time statistical analysis of SRB 
assay also proved significant results. The research performed here is very useful for set up of 
different extract studies of Bhringraj for its anticancer activity.  
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INTRODUCTION 
Medicinal plants and their Phytoconstituents 
are being increasingly used as corresponding 
treatment for cancer. The many researches and 
clinical studies proved that the beneficial effects of 
herbal medicines on treat and prevent the cancer. 
Herbal medicines were most commonly used group 
of treatments, increasing in utilize from 5.3% before 
the diagnosis of cancer to 13.9% after the diagnosis 
of cancer.[1] Medicinal herbs are considered by 
common people to be safe, having less side effects 
and likely to having low dependency.[2] Due to the 
harmful side effects of modern chemical drugs, 
people are being attracted to herbal medicinal 
preparations. Many ethno-pharmaceutical evidences 
showed that different medicinal herbs in the form of 
fresh juice can be best option for live diseases, 
Bhringraj (Eclipta alba Hassk.) is one of them. It is 
belonging to family Asteraceae. It is widely used by 
many tribes in India for multipurpose medicinal uses. 
Herbal resources can be taken as the best option for 
therapeutic as well as a preventive major in the 
patients of liver diseases. Different researches also 
proved that Bhringraj is having important 
pharmacological actions, which are proved by 
modern technology that’s why many Ayurvedic 
formulations are made up of Bhringraj as a main 
component. Here we planned to study anticancer 
activity of it against hepatocellular carcinoma.  
In present days it is challenge to world’s 
scientist to invent better medicine for cure and 
prevent the cancer. In our research study we use the 
herbal medicinal plant Bhringraj having Latin name 
Eclipta alba Hassk. and hepatic liver cancer cell line 
HepG2. Many of the Phytoconstituents in Eclipta alba 
having well known chemical constituent like 
wedelolactone, beta sitosterol, etc. There are 
approximately 53 to 55 chemical compounds present 
in it. [3] In Ayurveda Bhringraj has special attention 
for its Keshya (hair rejuvenation) action and is very 
commonly used in hair oils. But here we considered 
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in detail about its hepatoprotective activity of it. It is 
not possible to get fresh plant material all the time so, 
different extractions can be used for medicine uses. 
Different extraction solvents show presence of 
different active chemical compounds. We have 
evaluated and experimented different extracts of 
Bhringraj like ethanol, methanol, petroleum ether. In 
this research article we studied aqueous extract of 
Bhringraj for presence of different Phytoconstituents 
through phytochemical analysis, TLC, HPLC. After 
that with the help of srb assay we performed In vitro 
study of it. During study of different extracts of 
Bhringraj, every time we got better and positive 
results. Here purpose of our study is to put 
therapeutic and preventive herbal medicine option 
against hepatic carcinoma. Bhringraj itself means 
shining like Peacock, as the peacock is having 
different attractive colors, the same way Bhringraj 
shows its various shades of qualities.  
AIM OF THE STUDY 
The present study was designed to assess and 
establish the role of an aqueous extract of Eclipta 
alba as an anti-cancer agent using the HepG2 cell line. 
MATERIAL AND METHOD 
Plant Material 
Eclipta alba Hassk. was collected from 
Phulambri, District Aurangabad and the sample was 
authenticated at Head of the Botany Department, Dr. 
Babasaheb Ambedkar Marathwada University 
Aurangabad, India. Specimen sample of Eclipta 
alba Hassk. has been allotted a voucher sample 
accession number 0660 and kept at the medicinal 
plant repository of the institute. 
CELL LINE CULTURING: 
HepG2 cell line was used for study which was 
purchased from the National Centre for Cell Science 
(NCCS) Pune. HepG2 cell line was human liver cancer 
cell line. It was cultured in medium (MEM)E, ( Eagle’s 
Minimum Essential Media) containing 10% FBS 
(Foetal Bovine Serum). Culturing media was used of 
Hi Media Lab. Mumbai, Maharashtra, India. 
 
Fig 1: HepG2 cell line 
Preparation of an Aquous Extract of Eclipta alba 
First of all fresh sample of Eclipta alba was 
dried at room temperature for 8-10 days, the dried 
whole plant was then powdered with the help of an 
electric blender. Distilled water (H2O) used for the 
aqueous extraction of the Eclipta alba with the help 
of the soxhlet apparatus. 10gm of Eclipta alba in 
150ml Distilled water solution was used for 
extraction. 
 
Fig 2: Preparation of an aqueous extract of Eclipta 
alba 
Phytochemical Analysis of an Aqueous Extract Of 
Eclipta alba[4,5] 
An aqueous extract of Eclipta alba was screened for 
the presence of various Phytoconstituents using 
standard procedures. The phytochemical study was 
studied for the Carbohydrate, phenols, flavonoids, 
alkaloids, steroids, tannins, saponins, glycosides, 
quinones, amino acids and coumarin etc 
TLC Analysis of an Aqueous Extract of Eclipta alba 
The collected fractions of an aqueous extract 
of Eclipta alba Hassk. were further evaluated for Thin 
Layer Chromatography for that TLC plate (Merck, 
India) was used. The solvent system for TLC is 
Benzene: Chloroform (1:1). This was used as the 
mobile phase. The plate was soaked gently in the TLC 
jar containing above solvent. Solvents were moved 
until they reached the upper edge. Then the plate was 
removed from the jar and allowed to dry, spots were 
noted Rf values calculated according to the following 
equation. 
             The distance of the spot sample movement  
Retention factor = --------------------------------------------- 
               The distance of the spot solvent movement  
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HPLC Analysis of an Aqueous Extract of Eclipta 
alba [6] 
For obtaining the HPLC chromatogram of an 
aqueous extract of Eclipta alba, chromatographic 
conditions were optimized with the mobile phase and 
flow rate. Methanol, water, acetic acid (95:5:0.04) as 
a mobile phase in isocratic elution with a flow rate 
0.6ml/min provided better peak and shape 
resolution. The analysis was performed with a 
running time of 10 min. detector wavelength was 
352nm and the injection volume is 10ul. 
Cell Viability SRB Assay 
Sulphorhodamine B (SRB) assay kit was used 
of Hi-Media cell culture Laboratories, Mumbai, 
Maharashtra, India. It was employed for screening of 
anticancer activity of ethanolic extract of Eclipta alba. 
Using the Human hepatoma cell line (HEPG2). The 
Cell line was cultured in medium (MEM) E containing 
10% fetal bovine serum, 2mM L-glutamine and 
inoculated into 96 well micro titer plates in 100µL at 
plating densities. Cell inoculated and micro titer 
plates were incubated at 37°C, 5 % CO2, 95% air and 
100% relative humidity for 24h prior to the addition 
of extract. During extract addition, an aliquot of 
frozen concentrated (1mg/ml) was thawed and 
diluted to 25μg/ml, 50μg/ml, 75μg/ml and 100μg/ml 
with complete medium containing test article. 
Aliquots of extract (10µl) were mixed to appropriate 
microtiter wells containing 90µl of medium and final 
extract concentrations of 25μg/ml, 50μg/ml, 
75μg/ml, were obtained. The plates with plant 
extract concentrations were incubated at standard 
conditions for 48 hours and the assay was terminated 
by the addition of cold TCA (Trichloride Acetic Acid). 
50µl of cold 30% (w/v) TCA (final concentration, 
10% TCA) was added to fix the cells in situ and 
incubated for 60-70 minutes at 4°C. The supernatant 
fluid was discarded; plates were washed five times 
with tap water and air-dried. In each well SRB 
solution (50µl) at 0.4% (w/v) in 1 % acetic acid was 
added and it was incubated for 20 minutes at room 
temperature. One staining is completed, unbound dye 
was recovered and the residual dye was removed by 
washing five times with 1% acetic acid. The plates 
were air-dried and the bound stain was subsequently 
eluted with a 10 mM trizma base and absorbance was 
observed on ELISA reader (Thermo Fisher Scientific 
Company, Maharashtra, India) at a reference 
wavelength of 565nm with 610nm. The percentage of 
growth was calculated on a plate-by-plate basis for 
plant extract wells relative to control wells. Tabulate 
the results and calculate the percentage of viability. 
% cell growth (viability) = Absorbance sample/ 
Absorbance negative control or untreated x 100  
% growth inhibition = 100 - % cell growth [7] 
RESULTS AND DISCUSSION 
Ethanolic Extract 
10gm of Eclipta alba in 150ml of distilled 
water solution results in 1.5 gm an aqueous extract 
during this 6.9gm was the residual part. As a result, 
we can say that 15 % of an aqueous extract obtained 
from 10gm of a powered form of Eclipta alba. The 
yield of extract was 15% (w/w). 
  
 
Fig 3: An aqueous extract and residue of Eclipta alba 
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Phytochemical Analysis 
While studying the phytochemical analysis we found that phenol, Flavonoids, Tannins, Quinones, Amino 
acids and coumarin were present in an ethanolic extract of Eclipta alba.  
Table 1: Phytochemical analysis of an aqueous extract of Eclipta alba 
S.no. Phytochemicals  Test Result 
1. Carbohydrate Fehling’s test - 
2. Phenols Fecl3 test + 
3. Flavonoids NH3 test + 
4. Alkaloids Wagner’s test  - 
5. Steroids Salkowski’s test - 
6. Tannins Lead acetate test + 
7. Saponins Frothing test - 
8. Glycosides Nitroprusside test  - 
9. Quinones - + 
10. Amino acids Ninhydrin test + 
11. Coumarin UV light test + 
TLC Analysis 
TLC analysis shows 2 different spots and Rf values of the spots were - 0.81, 0.54. That proved that in the 
ethanolic extract of Eclipta alba had 2 active chemical constituents. 
 
Fig 4: TLC of an aqueous extract of Eclipta alba 
HPLC Analysis 
HPLC analysis showed the following result in which eight chemical compounds were observed at retention time 
shown in the below table. 
Table 2: HPLC analysis of aqueous extract of Eclipta alba 
No. Ret.Time Area Type Height Rel.Area 
 Min mAU*min  mAU % 
1 0.627 0.3235 BMB 0.978 5.08 
2 2.667 0.0001 BMB 0.005 0 
3 2.767 0.0001 BMB 0.004 0 
4 4.333 1.5544 BMB 4.529 24.43 
5 4.933 0.8733 BM 3.337 13.72 
6 5.38 2.8717 M 3.291 45.13 
7 8.02 0.1632 Mb 0.242 2.56 
8 9.427 0.5774 bMB 0.864 9.07 
 Total 6.3638  13.251 100 
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HPLC chromatogram for the aqueous extract of an Eclipta alba is shown in the following graph 
 
Fig 5: HPLC chromatogram of an aqueous extract of Eclipta alba 
Cell Viability SRB Assay 
The following table shows the readings of Elisa reader in which concentrations 25μg/ml, 50μg/ml and 
75μg/ml in quadruplet form as experiments 1, 2 and 3 and 4 were included. Experimental readings were 
optical densities for given concentrations at 565 nm wavelength. 
Table 3: Optical density readings of SRB assay 
Concentrations 25μg/ml 50μg/ml 75μg/ml  
Experiment O.D. O.D. O.D. O.D. (Media) 
1. 0.109 0.329 0.547 0.918 
2. 0.168 0.168 0.291 2.919 
3. 0.121 0.155 0.637 0.048 
4. 0.128 0.132 0.903 0.048 
Average  0.1315 0.196 0.594 0.983 
% cell growth 13.37 19.93 60.47 - 
% growth inhibition 86.63 80.07 39.53 - 
In vitro study of an aqueous extract of Eclipta alba shows positive results against HepG2 cell line, 
percentage of cell viability (growth) are 13.37%, 19.93%, 60.47% and percentage of growth inhibition are 
86.63%, 80.07% and 39.53% for 25μg/ml, 50μg/ml, 75μg/ml concentrations respectively. The average 
percentage of growth inhibition is 68.74%. 
Statistical Analysis 
Table 4: Statistical analysis 
 
 
 
 
 
 x1 x1* x1 x2 x2*x2 x3 x3*x3  
0.11 0.01 0.33 0.11 0.55 0.30 
0.17 0.03 0.17 0.03 0.29 0.08 
0.12 0.01 0.16 0.02 0.64 0.41 
 0.13 0.02 0.13 0.02 0.90 0.82 
Summations 0.53 0.07 0.79 0.18 2.38 1.61 
 0.28  0.61  5.65  
0.31 1.55 1.64 0.22 0.66 0.02 27.49 
CX SSR 1.35 SSW MSSA MSSW F Ratio 
 SSA  
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Source of variance df Ss Mss F ratio 
Among groups 2 0.22 4.50 27.49 
Within Groups 9 1.33 0.02 27.49 
Total  11 
Here we apply F-test for statistical analysis. 
We calculated the valuation of three concentrations 
25μg/ml, 50μg/ml, 75μg/ml of an aqueous extract of 
Eclipta alba against HepG2 cell line where 
quadruplets of optical densities were seen in Elisa 
reader. The degree of freedom among groups is 2 (n-
1) and the degree of freedom within the groups is 9 
(k-1). The sum of square (SS) value among the group 
is 0.22 and SS within the group is 1.33. The mean of 
the sum of square (MSS) value among the groups is 
4.50 and MSS within the groups is 0.02. Thus, 
calculated the F- ratio is 27.49 which, is significant at 
95% confidence and 5% level of significance. The F 
ratio is calculated with the help of the F ratio chart at 
the degree of freedom 2 and 9. 
CONCLUSION 
The present study revealed that an aqueous 
extract of Eclipta alba shows anticancer activity 
against the HepG2 cell line due to presence of active 
chemical compounds present in it. The presences of 
active chemical constituents present in the Eclipta 
alba are proved with the help of phytochemical 
analysis, TLC and HPLC analysis. The Cell viability 
SRB assay also shows significant growth inhibition, at 
the same time statistical analysis of SRB assay also 
proved significant results. Finally, we can say that all 
results of our study support the anticancer activity of 
an ethanolic extract of Eclipta alba against the HepG2 
cell line. 
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